UCP2 and cancer: Several studies have demonstrated that UCP2 is over-expressed in cancer cells, which attenuates oxidative stress by increasing proton influx into the mitochondrial matrix and by decreasing mitochondrial superoxide generation and electron leakage, supporting the notion that the mitigation of oxidative stress is an adaptive mechanism established by cancer cells for the homeostatic maintenance of reactive oxygen species (ROS) [21, 22].